PureTech Health plc Stock
Stocks
PRTC
GB00BY2Z0H74
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.20 GBX | -3.22% |
|
-8.66% | -3.84% |
| 07-02 | PureTech launches Celea Therapeutics with USD180 million financing | AN |
| 07-02 | PureTech Health Spins off Celea Therapeutics | MT |
| Market Cap | 391M 342M 314M 293M 555M 37.2B 563M 3.77B 1.46B 18.27B 1.47B 1.43B 63.04B | P/E 2026 * |
-3.51x | P/E 2027 * | -3.89x |
|---|---|---|---|---|---|
| Enterprise Value | 129M 112M 103M 96.37M 183M 12.24B 185M 1.24B 482M 6.01B 483M 472M 20.75B | EV / Sales 2026 * |
18.1x | EV / Sales 2027 * | 9.98x |
| Free-Float |
84.5% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: PureTech Health plc
| 1 day | -3.22% | ||
| 1 week | -8.66% | ||
| Current month | -12.52% | ||
| 1 month | -7.54% | ||
| 3 months | +6.37% | ||
| 6 months | -3.53% | ||
| Current year | -3.84% |
| 1 week | 115 |  | 140.02 |
| 1 month | 115 | | 140.02 |
| Current year | 107.4 | | 143.6 |
| 1 year | 104.71 | | 148 |
| 3 years | 100.4 | | 238.5 |
| 5 years | 100.4 | | 410.66 |
| 10 years | 100.4 | | 447.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Lyne
CEO | Chief Executive Officer | 43 | 2025-07-14 |
Eric Elenko
PSD | President | 53 | 2024-04-08 |
Charles Sherwood
COO | Chief Operating Officer | - | 2021-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Langer
BRD | Director/Board Member | 76 | 2015-05-07 |
John LaMattina
BRD | Director/Board Member | 76 | 2008-12-31 |
| Director/Board Member | 73 | 2020-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-12 | Buy | Founder | 112,509 | 0.0466% | ||
| 25-09-23 | Buy | Chief Executive Officer | 81,051 | 0.0337% | ||
| 25-09-23 | Buy | Chairman | 65,250 | 0.0272% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.22% | -8.66% | -5.21% | -44.74% | 404M | |
| +1.70% | +6.89% | +2.76% | +7.65% | 49.15B | |
| +0.92% | +6.21% | +408.85% | +607.44% | 40.23B | |
| +1.89% | +11.06% | +25.75% | -7.89% | 34.55B | |
| +2.38% | +8.10% | +21.83% | +66.94% | 33.09B | |
| +3.96% | +6.07% | +14.14% | +37.68% | 25.19B | |
| +2.51% | +4.94% | - | - | 17.05B | |
| +2.58% | +7.24% | +71.03% | +132.17% | 15.92B | |
| +0.32% | +1.58% | +14.34% | +19.26% | 13.83B | |
| -1.14% | +7.52% | +14.75% | -30.83% | 13.26B | |
| Average | +1.19% | +4.83% | +63.14% | +87.52% | 24.27B | |
| Weighted average by Cap. | +1.80% | +6.29% | +88.97% | +131.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.1M 6.21M 5.7M 5.32M 10.08M 676M 10.23M 68.47M 26.62M 332M 26.66M 26.08M 1.15B | 13.47M 11.78M 10.81M 10.09M 19.12M 1.28B 19.4M 130M 50.48M 630M 50.56M 49.46M 2.17B |
| Net income | -124M -109M -99.61M -92.99M -176M -11.81B -179M -1.2B -465M -5.8B -466M -456M -20.02B | -96.97M -84.81M -77.83M -72.66M -138M -9.23B -140M -935M -363M -4.53B -364M -356M -15.64B |
| Net Debt | -262M -229M -210M -196M -372M -24.95B -378M -2.53B -983M -12.25B -984M -963M -42.29B | -256M -224M -206M -192M -364M -24.4B -369M -2.47B -961M -11.98B -962M -941M -41.35B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | GBX 120.20 | -3.22% | 1,262,444 |
| 26-07-02 | GBX 124.20 | -5.91% | 1,826,104 |
| 26-07-01 | GBX 132.00 | -3.93% | 267,576 |
| 26-06-30 | GBX 137.40 | +2.54% | 888,297 |
| 26-06-29 | GBX 134.00 | +2.13% | 445,627 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PRTC Stock
Select your edition
All financial news and data tailored to specific country editions
